Why rapid at-home COVID tests are still pending FDA approval

Rapid at-home tests might help remind people to consider how they operate in the world and whether they’re infectious, especially as COVID-19 continues to evolve. That’s according to Bryan Walsh, Axios correspondent who covers emerging technology and global trends.

Rapid at-home tests might help remind people to consider how they operate in the world and whether they’re infectious, especially as COVID-19 continues to evolve. That’s according to Bryan Walsh, Axios correspondent who covers emerging technology and global trends. Image by Alexandra_Koch from Pixabay

Innova Medical Group, based in Pasadena, has developed a test people can buy over the counter and use at home. It costs $5 and produces results in about 30 minutes. It’s complete with a nasal swab, chemical solution, and paper-like strip. Innova Medical Group has been waiting for FDA approval since August. 

From this Episode:

Credits

Host:

Madeleine Brand

Producers:

Sarah Sweeney, Angie Perrin, Michell Eloy, Amy Ta, Rosalie Atkinson, Brian Hardzinski, Bennett Purser